LIB Therapeutics Inc. (LIB), a privately-held, late-stage biopharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License ...
Nuclear energy is crucial for meeting future energy demands as non-renewable resources dwindle and technological needs grow, with projections estimating it ...